NK cells produce chemoattractants, such as CCL5 and XCL1, that recruit cDC1s to tumor sites (7), meanwhile, tumor-derived factors, such as PGE2, can suppress NK cell viability and chemokine production. This evidence concerns the gene CCL5 and neoplasm.